4
Changes in Ownership
PUMA BIOTECHNOLOGY, INC. Filed Acc 0001437749-24-022065
Chief Commercial Officer sold 6,051 shares at $3.27 ($19,778)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ludwig Jeffrey Jerome Chief Commercial Officer | 2024-07-02 | Sale 10b5-1 | −6,051 | $3.27 | $19,778 | 120,986 | D |
| Open-market sales · 6,051 sh · avg $3.27 · $19,778 | |||||||
Loading xslF345X05/rdgdoc.xml…